Treatment outcome and germline predictive factors of ropeginterferon alpha-2b in myeloproliferative neoplasm patients.
Chih-Cheng ChenMing-Chung KuoYing-Hsuan WangSung-Nan PeiMing-Lih HuangChiu-Chen ChenCih-En HuangYi-Yang ChenLee-Yung ShihPublished in: Cancer medicine (2024)
Overall, this study provided valuable information on the ethnics- and genetics-based algorithm in the treatment of MPN.